SDC4 and dilated cardiomyopathy: Furthermore, high serum levels of syndecan-4 had been identified as a significant predictor of heart failure in hypertensive patients, and syndecan-4 was also considered a suitable biomarker for adverse left ventricular remodeling in patients with dilated cardiomyopathy (24).